0
ARTICLE |

Evidence for a 1980 HTLV-III Infection in a Currently Asymptomatic B Hemophiliac in Italy

Oliviero E. Varnier, MD; Giovanni Melioli, MD; Annalisa Merli, PhD; Gian Carlo Schito, MD; Gabriela Tudor, PhD; Elio Boeri, MD; Angelo C. Molinari, MD; Pier Giorio Mori, MD
JAMA. 1985;254(11):1449-1450. doi:10.1001/jama.1985.03360110039011.
Text Size: A A A
Published online

To the Editor.—  Seroconversion for antibody to human T-cell lymphotropic virus type III (HTLV-III) in hemophiliacs began shortly after the beginning of the acquired immunodeficiency syndrome (AIDS) epidemic among homesexual men and intravenous drug users (1979-1980). The first case of seropositivity was observed in 1978 in a 2-year-old child who had received blood transfusions as well as factor VIII concentrate.1 The seropositivity among European hemophiliacs has been reported to date back to 19812,3 following exposure to HTLV-III via some factor VIII concentrates obtained from the United States.4We have tested several sequentially collected serum samples (1979 to 1985) from about 100 Italian hemoDetection of Anti-HTLV-III Antibodies by ELISA and Western Blot Assays* Intensity Score for Antibodies to HTLV-III Date of ELISA Serum Collection Index p15 p24 p31 p41 p55 p61 10/28/80 4.7 2 1 0 0 0 0 3/1/85 >15 4 1 3 4 2 2

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs